Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H van Rennes

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|August 1, 1987
Modulation of placental alkaline phosphatase activity and cytokeratins in human HN-1 cells by butyrate, retinoic acid, catecholamines and histamineJ T Bijman, D J Wagener, H van Rennes, et al.
Clinical and Experimental Immunology|December 1, 1983
Characterization of monocyte maturation in adherent and suspension cultures and its application to study monocyte differentiation in Hodgkin's diseaseP H de Mulder, H van Rennes, P D Mier, et al.
Anti-Cancer Drugs|February 1, 1994
Concentration and sequence dependent synergism of ethyldeshydroxy-sparsomycin in combination with antitumor agentsH P Hofs, D J Wagener, V de Valk-Bakker, et al.
Anti-Cancer Drugs|April 1, 1997
The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activityH P Hofs, T D Wagener, V de Valk-Bakker, et al.
Investigational New Drugs|December 1, 1988
In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor modelsZ Zylicz, D J Wagener, H van Rennes, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1983
Altered intracellular enzyme activity of monocytes and lymphocytes in Hodgkin's diseaseP H de Mulder, P D Mier, B E de Pauw, et al.
The British Journal of Dermatology|September 1, 1983
Response of the clinically uninvolved skin of psoriatic patients to standardized injuryP C van de Kerkhof, H van Rennes, R M de Grood, et al.
Anticancer Research|November 1, 1989
Modulation of the in vitro cytotoxicity of seven anticancer drugs by protein synthesis inhibition using sparsomycinZ Zylicz, H P Hofs, D J Wagener, et al.
The Journal of Investigative Dermatology|February 1, 1984
Monocyte function is normal in quiescent psoriasisJ P Geerdink, P H de Mulder, M R Franzen, et al.
Anticancer Research|July 1, 1989
Studies on retinotoxic potential of a novel antitumor antibiotic--sparsomycin--in ratsZ Zylicz, W J De Grip, D J Wagener, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|August 1, 1987
Modulation of placental alkaline phosphatase activity and cytokeratins in human HN-1 cells by butyrate, retinoic acid, catecholamines and histamineJ T Bijman, D J Wagener, H van Rennes, et al.
Clinical and Experimental Immunology|December 1, 1983
Characterization of monocyte maturation in adherent and suspension cultures and its application to study monocyte differentiation in Hodgkin's diseaseP H de Mulder, H van Rennes, P D Mier, et al.
Anti-Cancer Drugs|February 1, 1994
Concentration and sequence dependent synergism of ethyldeshydroxy-sparsomycin in combination with antitumor agentsH P Hofs, D J Wagener, V de Valk-Bakker, et al.
Anti-Cancer Drugs|April 1, 1997
The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activityH P Hofs, T D Wagener, V de Valk-Bakker, et al.
Investigational New Drugs|December 1, 1988
In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor modelsZ Zylicz, D J Wagener, H van Rennes, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1983
Altered intracellular enzyme activity of monocytes and lymphocytes in Hodgkin's diseaseP H de Mulder, P D Mier, B E de Pauw, et al.
The British Journal of Dermatology|September 1, 1983
Response of the clinically uninvolved skin of psoriatic patients to standardized injuryP C van de Kerkhof, H van Rennes, R M de Grood, et al.
Anticancer Research|November 1, 1989
Modulation of the in vitro cytotoxicity of seven anticancer drugs by protein synthesis inhibition using sparsomycinZ Zylicz, H P Hofs, D J Wagener, et al.
The Journal of Investigative Dermatology|February 1, 1984
Monocyte function is normal in quiescent psoriasisJ P Geerdink, P H de Mulder, M R Franzen, et al.
Anticancer Research|July 1, 1989
Studies on retinotoxic potential of a novel antitumor antibiotic--sparsomycin--in ratsZ Zylicz, W J De Grip, D J Wagener, et al.
Pageof 3